Latest Articles

Publication Date
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org

Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org

Published: May 29, 2026, 11:56 p.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork

Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork

Published: May 29, 2026, 10:40 p.m.
mRNA Therapy Offers Hope for Uterine Factor Infertility - Technology Networks

mRNA Therapy Offers Hope for Uterine Factor Infertility Technology Networks

Published: May 28, 2026, 2:57 p.m.
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer - HMP Global Learning Network

Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer HMP Global Learning Network

Published: May 26, 2026, 4:46 p.m.
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations - CancerNetwork

Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations CancerNetwork

Published: May 25, 2026, 1:56 p.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times

Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times

Published: May 22, 2026, 4:14 p.m.
New therapy bests chemo to improve survival in endometrial cancer - Rare Cancer News

New therapy bests chemo to improve survival in endometrial cancer Rare Cancer News

Published: May 20, 2026, 1:14 p.m.
The Four Types of Therapy for Second-Line Endometrial Cancer - CancerNetwork

The Four Types of Therapy for Second-Line Endometrial Cancer CancerNetwork

Published: May 16, 2026, 2:04 p.m.
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor - Femtech Insider

Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor Femtech Insider

Published: May 15, 2026, 11:33 a.m.
UM research team identifies novel targeted therapy for endometrial cancer - University of Macau

UM research team identifies novel targeted therapy for endometrial cancer University of Macau

Published: May 13, 2026, 3:13 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!